Opportunity Information: Apply for RFA IP 11 007
Apply for RFA IP 11 007
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Economic Studies of Vaccines and Immunization Policies, Programs and Practices" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Jan 10, 2011 and posted on Jan 10, 2011.
- Applicants must submit their applications by Apr 12, 2011 On time submission requires that electronic applications be error free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 500 PM Eastern Time. NoteHHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled Economic Studies of Vaccines and Immunization Policies, Programs and Practices (Funding Opportunity Number RFA-IP-11-007) was a CDC discretionary funding announcement designed to support research focused on the economics of vaccines and immunization. Its core purpose was to fund economic studies that could directly inform the work of the CDCs National Center for Immunization and Respiratory Diseases (NCIRD), particularly in how it develops and supports policy related to vaccines and vaccination programs. In practical terms, the intent was to build an evidence base around costs, benefits, and broader economic impacts of immunization strategies so that policy and program decisions could be grounded in rigorous economic analysis rather than clinical or epidemiologic outcomes alone.
This opportunity was offered through a cooperative agreement, which signals a more hands-on funding relationship than a standard grant. Under a cooperative agreement, CDC typically anticipates substantial involvement during the period of performance, such as collaborating on study focus, aligning analyses with agency priorities, coordinating on data needs, or helping ensure that findings are structured in a way that is usable for policy and program decisions. The funding activity category was Health, and the CFDA listing associated with the announcement was 93.185 (Immunization Research, Demonstration, Public Information and Education), reflecting the programs broader orientation toward improving immunization practice and policy through applied research and related activities.
The announcement anticipated making one award, indicating a single, concentrated investment rather than multiple smaller projects. The posting date and creation date were both January 10, 2011, with an application deadline of April 12, 2011. Submission requirements emphasized that applications had to be submitted electronically through Grants.gov and validated in eRA Commons by 5:00 PM Eastern Time on the due date. A key administrative point was that CDCs process did not provide an error-correction window after the deadline; applications needed to be error-free and fully validated by the cutoff time, or they would not be considered on time. The opportunity was later archived on May 12, 2011, which is consistent with a time-limited solicitation that is no longer accepting applications.
Eligibility was listed as unrestricted, meaning it was open to a wide range of applicant organizations, subject to any clarifications contained in the full announcement text. The notice also stated that there was no cost sharing or matching requirement, lowering barriers for applicants that might not be able to commit non-federal funds. The award ceiling and floor were both listed as zero in the summary data, which usually means the amount was either determined elsewhere in the full announcement or was not populated in the abstracted fields, rather than implying that no funding was available.
For applicants or others needing assistance accessing the full announcement, the listed point of contact was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), with a phone number of 770-488-2700. Overall, the opportunity was essentially a targeted CDC investment in vaccine and immunization economic research intended to strengthen and guide real-world policy development and program decision-making within NCIRD.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled Economic Studies of Vaccines and Immunization Policies, Programs and Practices, and the Funding Opportunity Number is RFA-IP-11-007.
Which federal agency offered this opportunity?
This was a CDC discretionary funding announcement.
What was the main purpose of this funding opportunity?
The purpose was to support research focused on the economics of vaccines and immunization, building evidence on costs, benefits, and broader economic impacts of immunization strategies so that vaccine policy and program decisions could be informed by rigorous economic analysis (not only clinical or epidemiologic outcomes).
Which CDC center was this research intended to inform?
The research was intended to directly inform the work of the CDC's National Center for Immunization and Respiratory Diseases (NCIRD), particularly in how NCIRD develops and supports policy related to vaccines and vaccination programs.
What type of award mechanism was used?
This opportunity was offered through a cooperative agreement.
What does it mean that this was a cooperative agreement?
A cooperative agreement generally indicates a more hands-on funding relationship than a standard grant. For this opportunity, CDC anticipated substantial involvement during the period of performance, such as collaborating on study focus, aligning analyses with CDC priorities, coordinating on data needs, and helping ensure findings are usable for policy and program decisions.
What was the funding activity category?
The funding activity category was Health.
What CFDA program listing was associated with this announcement?
The CFDA listing associated with the announcement was 93.185, titled Immunization Research, Demonstration, Public Information and Education.
How many awards were anticipated?
The announcement anticipated making one award, suggesting a single, concentrated investment rather than multiple smaller projects.
When was the opportunity posted?
The posting date (and creation date) was January 10, 2011.
What was the application deadline?
The application deadline was April 12, 2011.
How were applications required to be submitted?
Applications had to be submitted electronically through Grants.gov and validated in eRA Commons by the deadline.
What time were applications due, and what time zone applied?
Applications needed to be fully submitted and validated by 5:00 PM Eastern Time on the due date.
Was there an error-correction window after submission?
No. The CDC process described in the opportunity did not provide an error-correction window after the deadline. Applications needed to be error-free and fully validated by the cutoff time or they would not be considered on time.
Is this opportunity still accepting applications?
No. The opportunity was archived on May 12, 2011, consistent with a time-limited solicitation that is no longer accepting applications.
Who was eligible to apply?
Eligibility was listed as unrestricted, meaning it was open to a wide range of applicant organizations, subject to any clarifications contained in the full announcement text.
Was cost sharing or matching required?
No. The notice stated there was no cost sharing or matching requirement.
How much funding was available under this opportunity?
In the summary data, the award ceiling and floor were both listed as zero. This typically indicates the funding amount was determined elsewhere in the full announcement or the fields were not populated in the abstracted summary, rather than implying that no funding was available.
What kinds of research did CDC want to support through this announcement?
The opportunity was designed to fund economic studies related to vaccines and immunization policies, programs, and practices, especially analyses that could support real-world decision-making by NCIRD by clarifying economic tradeoffs and impacts of immunization strategies.
Who could be contacted for help accessing the full announcement?
The listed point of contact was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), reachable by phone at 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: The Incidence and Etiology of Influenza Associated Community Acquired Pneumonia in Hospitalized Persons Study
Previous opportunity: Strategies to Improve Vaccination Coverage of Children in Child Care Centers (CCCs) and Preschools.
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 11 007
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 11 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| The Incidence and Etiology of Influenza Associated Community Acquired Pneumonia in Hospitalized Persons Study Apply for RFA IP 11 011 Funding Number: RFA IP 11 011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Conference Support Program Apply for CDC RFA EH11 1105 Funding Number: CDC RFA EH11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Service Area Competition Additional Areas Apply for HRSA 11 163 Funding Number: HRSA 11 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Delta Health Initiative Apply for HRSA 11 090 Funding Number: HRSA 11 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition A Consortium to Study Genetics of Longevity (U19) Apply for PAR 11 101 Funding Number: PAR 11 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| EIS Ongoing Expansion Funds for Current Part C Grantees Apply for HRSA 11 092 Funding Number: HRSA 11 092 Agency: Health Resources and Services Administration Category: Health Funding Amount: $200,000 |
| Ethiopia Comprehensive HIV AIDS Treatement Care and Support Program Apply for RFA 663 11 000005 Funding Number: RFA 663 11 000005 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $42,000,000 |
| Pediatric Device Consortia Grant Program (P50) Apply for RFA FD 11 002 Funding Number: RFA FD 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Programs to Improve the Health and Educational Outcomes of Young People Apply for CDC RFA DP11 1101 Funding Number: CDC RFA DP11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Implementation of Programs to Improve Quality Laboratory Services in support of HIV/AIDS Care, Support and Treatment at the University Teaching Hospital Antiretroviral Clinic and Laboratory in the Republic of Zambia under PEPFAR Apply for CDC RFA GH11 1121 Funding Number: CDC RFA GH11 1121 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the National Reference Laboratory to Perform and Oversee Laboratory Services in Rwanda under the President s Emergency Plan for AIDS Relief (PEPFAR) and the Global Health Initiative Apply for CDC RFA GH11 1163 Funding Number: CDC RFA GH11 1163 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Drug Free Communities Support Program Apply for SP 11 002 Funding Number: SP 11 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Capacity Building and Sustainability to Strengthen the Epidemiology and Laboratory Management Public Health Infrastructure of the Republic of Angola Apply for CDC RFA GH11 1186 Funding Number: CDC RFA GH11 1186 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH) (U01) Apply for RFA GH 11 002 Funding Number: RFA GH 11 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition for State Planning and Establishment Grants for the Affordable Care Acts Exchanges Apply for IE HBE 11 002 Funding Number: IE HBE 11 002 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: $1,000,000 |
| Development, Maintenance and Enhancement of Early Hearing Detection and Intervention Information System (EHDI IS) Surveillance Programs Apply for CDC RFA DD11 1101 Funding Number: CDC RFA DD11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $175,000 |
| Support for the National Government Monitoring and Evaluation System, Surveillance and Laboratory Infrastructure, and Pediatric and Adult HIV Care and Support in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 91210201SUPP11 Funding Number: CDC RFA PS09 91210201SUPP11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Emergency Medical Services for Children (EMSC) Network Development Demonstration Project Apply for HRSA 11 079 Funding Number: HRSA 11 079 Agency: Health Resources and Services Administration Category: Health Funding Amount: $630,000 |
| Affordable Care Act (ACA) Childhood Obesity Research Demonstration Apply for RFA DP 11 007 Funding Number: RFA DP 11 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,250,000 |
| Ancillary Studies in Clinical Trials (R01) Apply for RFA HL 12 012 Funding Number: RFA HL 12 012 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 11 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.